Best Cannabis (Marijuana) Stocks to Trade

The cannabis industry could see its best year yet in 2021

With a rise in medical marijuana use, the industry is projected to triple over the next several years. As such, many prospective and current cannabis investors are searching for ways to capitalize. With more states and countries eliminating the penalties for cannabis (and its parts).

The majority of cannabis biotech firms are ramping up their production to meet the skyrocketing demand for medical cannabis.

Are you interested in cannabis stocks but don’t know where to begin?

1.) GW Pharmaceuticals (NASDAQ: GWPH‎)

This British biopharmaceutical company focuses its efforts on plant-derivative cannabinoid treatments. Epidiolex is the company’s primary product. It was the first drug the U.S.

Food and Drug Administration approved for seizure treatment related to an array of diseases such as Dravet syndrome, Lennox-Gastaut syndrome and tuberous sclerosis complex.

 

2.) Canopy Growth CGC (NASDAQ: CGC – formerly called Tweed Marijuana, Inc.)

In 2013, Chuck Rificiin and Bruce Linton founded Canopy Growth Corporation. Based in Ontario, Canada, the company is a reputable medical marijuana producer and is the world’s most prominent cannabis company when looking at market capitalization. During this time, Constellation Brands, Inc. owned more than 35 percent of Canopy, which employed about 3,200 people.

In 2019, the company faced significant challenges, which led to a 32 percent decline in stock price.

 

3.) Aurora Cannabis (NYSE: ACB)

Based in Edmonton, this Canadian company is listed as ACB on both the New York and Toronto Stock Exchanges.

In September 2018, the company had operations in 25 countries, with eight accredited manufacturing facilities and five sales licenses. In just Canada, Aurora Cannabis had a more than 625,000-kilogram cannabis production, with its market expanding to Latin America and Denmark.

Aurora is the world’s second-biggest cannabis company

 

4.) Tilray (NASDAQ: TLRY)

This Canadian drug and cannabis corporation with places of operations in the U.S. regards itself as the chief, most refined premium medical cannabis manufacturer. Its headquarters are in Toronto, but operations can be found throughout the world, such as Australia, Germany, Latin America, New Zealand and Portugal.

In December 2020, an acquisition by Aphria was publicized.

 

5.) Plus 500 Cannabis Stock Index

The Plus500 Cannabis Index looks at the 20 leading listed cannabis-related companies and their Gross Total Return Performance.